Striatal pathology underlies prion infection-mediated hyperactivity in mice

References

• Aguzzi A, O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 2010; 9:237 - 248
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105 - 1152
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 1135
   PubMed Web of Science ®Google Scholar
• Jackson WS, Borkowski AW, Faas H, Steele AD, King OD, Watson N, et al. Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 2009; 63:438 - 450
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci USA 2009; 106:304 - 309
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M. Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007; 8:552 - 561
   PubMed Web of Science ®Google Scholar
• Morales R, Abid K, Soto C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta 2007; 1772:681 - 691
   PubMed Web of Science ®Google Scholar
• Steele AD, Hetz C, Yi CH, Jackson WS, Borkowski AW, Yuan J, et al. Prion pathogenesis is independent of caspase-12. Prion 2007; 1:243 - 247
   PubMed Web of Science ®Google Scholar
• Steele AD, King OD, Jackson WS, Hetz CA, Borkowski AW, Thielen P, et al. Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo. J Neurosci 2007; 27:13022 - 13027
   PubMed Web of Science ®Google Scholar
• Steele AD, Hutter G, Jackson WS, Heppner FL, Borkowski AW, King OD, et al. Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease. Proc Natl Acad Sci USA 2008; 105:13626 - 13631
   PubMed Web of Science ®Google Scholar
• Chen D, Steele AD, Hutter G, Bruno J, Govindarajan A, Easlon E, et al. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp Gerontol 2008; 43:1086 - 1093
   PubMed Web of Science ®Google Scholar
• Riemer C, Schultz J, Burwinkel M, Schwarz A, Mok SW, Gultner S, et al. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice. J Virol 2008; 82:12464 - 12471
   PubMed Web of Science ®Google Scholar
• White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci USA 2008; 105:10238 - 10243
   PubMed Web of Science ®Google Scholar
• Khurgel M, Switzer RC 3rd, Teskey GC, Spiller AE, Racine RJ, Ivy GO. Activation of astrocytes during epileptogenesis in the absence of neuronal degeneration. Neurobiol Dis 1995; 2:23 - 35
   PubMed Web of Science ®Google Scholar
• Brendza RP, O'Brien C, Simmons K, McKeel DW, Bales KR, Paul SM, et al. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic and synaptic structures. J Comp Neurol 2003; 456:375 - 383
   PubMed Web of Science ®Google Scholar
• Switzer RC 3rd. Application of silver degeneration stains for neurotoxicity testing. Toxicol Pathol 2000; 28:70 - 83
   PubMed Web of Science ®Google Scholar
• Kreitzer AC, Malenka RC. Striatal plasticity and basal ganglia circuit function. Neuron 2008; 60:543 - 554
   PubMed Web of Science ®Google Scholar
• Graybiel AM. Habits, rituals and the evaluative brain. Annu Rev Neurosci 2008; 31:359 - 387
   PubMed Web of Science ®Google Scholar
• Martin S, van den Buuse M. Phencyclidine-induced locomotor hyperactivity is enhanced in mice after stereotaxic brain serotonin depletion. Behav Brain Res 2008; 191:289 - 293
   PubMed Web of Science ®Google Scholar
• Zhou FM, Liang Y, Salas R, Zhang L, De Biasi M, Dani JA. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 2005; 46:65 - 74
   PubMed Web of Science ®Google Scholar
• Vidal C, Herzog C, Haeberle AM, Bombarde C, Miquel MC, Carimalo J, et al. Early dysfunction of central 5-HT system in a murine model of bovine spongiform encephalopathy. Neuroscience 2009; 160:731 - 743
   PubMed Web of Science ®Google Scholar
• Guentchev M, Hainfellner JA, Trabattoni GR, Budka H. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1997; 56:1119 - 1124
   PubMed Web of Science ®Google Scholar
• Belichenko PV, Miklossy J, Belser B, Budka H, Celio MR. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease. Neurobiol Dis 1999; 6:269 - 279
   PubMed Web of Science ®Google Scholar
• Avale ME, Faure P, Pons S, Robledo P, Deltheil T, David DJ, et al. Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion. Proc Natl Acad Sci USA 2008; 105:15991 - 15996
   PubMed Web of Science ®Google Scholar
• Drenan RM, Grady SR, Steele AD, McKinney S, Patzlaff NE, McIntosh JM, et al. Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors. J Neurosci 2010; 30:9877 - 9889
   PubMed Web of Science ®Google Scholar
• Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM, et al. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha6 nicotinic acetylcholine receptors. Neuron 2008; 60:123 - 136
   PubMed Web of Science ®Google Scholar
• Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009; 10:211 - 223
   PubMed Web of Science ®Google Scholar
• O'Neil JN, Mouton PR, Tizabi Y, Ottinger MA, Lei DL, Ingram DK, et al. Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice. J Chem Neuroanat 2007; 34:102 - 107
   PubMed Web of Science ®Google Scholar
• Bruce ME, Fraser H. Scrapie strain variation and its implications. Current Topics in Microbiology and Immunology 1991; 172:125 - 138
   PubMedGoogle Scholar
• Dell'Omo G, Vannoni E, Vyssotski AL, Di Bari MA, Nonno R, Agrimi U, et al. Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 2002; 16:735 - 742
   PubMed Web of Science ®Google Scholar
• Jhuang H, Garrote E, Yu X, Khilnani V, Poggio T, Steele AD, et al. Automated home-cage behavioral phenotyping of mice. Nature Communications 2010; 1:68
   PubMed Web of Science ®Google Scholar
• Ayers JI, Kincaid AE, Bartz JC. Prion strain targeting independent of strain-specific neuronal tropism. J Virol 2009; 83:81 - 87
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992; 66:2096 - 2101
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329 - 334
   PubMed Web of Science ®Google Scholar
• Cunningham C, Deacon RM, Chan K, Boche D, Rawlins JN, Perry VH. Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis 2005; 18:258 - 269
   PubMed Web of Science ®Google Scholar
• Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, Pastan I, et al. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci 2003; 23:9078 - 9088
   PubMed Web of Science ®Google Scholar
• Gantois I, Fang K, Jiang L, Babovic D, Lawrence AJ, Ferreri V, et al. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity and impaired oral behavior. Proc Natl Acad Sci USA 2007; 104:4182 - 4187
   PubMed Web of Science ®Google Scholar
• Unger EL, Eve DJ, Perez XA, Reichenbach DK, Xu Y, Lee MK, et al. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol Dis 2006; 21:431 - 443
   PubMed Web of Science ®Google Scholar
• Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background and developmental adaptations. J Neurosci 1998; 18:3470 - 3479
   PubMed Web of Science ®Google Scholar
• Smits SM, Noorlander CW, Kas MJ, Ramakers GM, Smidt MP. Alterations in serotonin signalling are involved in the hyperactivity of Pitx3-deficient mice. Eur J Neurosci 2008; 27:388 - 395
   PubMed Web of Science ®Google Scholar
• Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, et al. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 1999; 96:10483 - 10488
   PubMed Web of Science ®Google Scholar
• Gray BC, Siskova Z, Perry VH, O'Connor V. Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology. Neurobiol Dis 2009; 35:63 - 74
   PubMed Web of Science ®Google Scholar
• Siskova Z, Mahad DJ, Pudney C, Campbell G, Cadogan M, Asuni A, et al. Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease. Am J Pathol 2010; 177:1411 - 1421
   PubMed Web of Science ®Google Scholar
• Siskova Z, Page A, O'Connor V, Perry VH. Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. Am J Pathol 2009; 175:1610 - 1621
   PubMed Web of Science ®Google Scholar
• Siskova Z, Sanyal NK, Orban A, O'Connor V, Perry VH. Reactive hypertrophy of synaptic varicosities within the hippocampus of prion-infected mice. Biochem Soc Trans 2010; 38:471 - 475
   PubMed Web of Science ®Google Scholar
• Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 1132
   PubMed Web of Science ®Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367 - 6374
   PubMed Web of Science ®Google Scholar
• Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem 2010; 285:26377 - 26383
   PubMed Web of Science ®Google Scholar
• Kellett KA, Hooper NM. Prion protein and Alzheimer disease. Prion 2009; 3:190 - 194
   PubMed Web of Science ®Google Scholar
• Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci USA 2010; 107:2295 - 2300
   PubMed Web of Science ®Google Scholar
• Steele AD, Zhou Z, Jackson WS, Zhu C, Auluck P, Moskowitz MA, et al. Context dependent neuroprotective properties of prion protein (PrP). Prion 2009; 3:240 - 249
   PubMed Web of Science ®Google Scholar
• Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2010; 2:306 - 314
   PubMed Web of Science ®Google Scholar
• Jeong BH, Lee KH, Jeong YE, Hwang KA, Lee YJ, Carp RI, et al. Polymorphisms at codons 129 and 219 of the prion protein gene (PRNP) are not associated with sporadic Alzheimer's disease in the Korean population. Eur J Neurol 2007; 14:621 - 626
   PubMed Web of Science ®Google Scholar
• Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123:1191 - 1201
   PubMed Web of Science ®Google Scholar
• Steele AD, Jackson WS, King OD, Lindquist S. The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. Proc Natl Acad Sci USA 2007; 104:1983 - 1988
   PubMed Web of Science ®Google Scholar
• de Olmos JS, Beltramino CA, de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia and physical trauma. Neurotoxicol Teratol 1994; 16:545 - 561
   PubMed Web of Science ®Google Scholar
• Gundersen HJ, Jensen EB, Kieu K, Nielsen J. The efficiency of systematic sampling in stereology—reconsidered. J Microsc 1999; 193:199 - 211
   PubMed Web of Science ®Google Scholar
• Manaye KF, Wang PC, O'Neil JN, Huang SY, Xu T, Lei DL, et al. Neuropathological quantification of dtg APP/PS1: neuroimaging, stereology and biochemistry. Age (Dordr) 2007; 29:87 - 96
   PubMed Web of Science ®Google Scholar